An unsuccessful IVF cycle is rarely explained by a single factor. Assessment should review the entire process, from ovarian response and embryo development to the uterine environment and embryo transfer technique.
A problem may arise at different stages of treatment.
Not every additional test or intervention is routinely necessary.
Embryology reports are among the most important sources of information.
Why does IVF fail? Receiving a negative pregnancy test after IVF can be emotionally as well as medically difficult. A common first reaction is to ask “What did I do wrong?” or “Why did the embryo not implant?” In most cases, IVF failure is not caused by ordinary activities such as going to work, climbing stairs, moving around or not resting enough.
IVF is a multi-stage process. Ovarian response to medication, egg maturity, sperm characteristics, fertilisation, embryo development, chromosome status, the uterine environment and the transfer procedure can all contribute to the outcome. Sometimes a specific explanation is identified; in other cases, available tests do not provide one clear cause. The purpose of a second opinion is not to add an expensive “add-on” after every unsuccessful cycle, but to review the treatment step by step.
At which stage did the treatment fail?
The first step is to review treatment as a sequence of stages rather than as a single final result:
- How did the ovaries respond to stimulation?
- How many eggs were collected and how many were mature?
- What was the fertilisation rate?
- How did the embryos develop through days 3 and 5?
- What were the characteristics of the transferred embryo?
- What were the endometrial and transfer conditions?
- If pregnancy occurred, at what stage did it end?
For example, if many eggs were obtained but fertilisation did not occur, sperm–egg interaction and the laboratory method may be reviewed. If fertilisation was satisfactory but embryos did not reach the blastocyst stage, egg, sperm and embryo-development data should be considered together. If a well-developed embryo was transferred but pregnancy did not occur, the uterine environment, embryo chromosome status and transfer process may be assessed.
Ovarian response and egg maturity
Age, ovarian reserve and the stimulation protocol affect the number of eggs obtained. Development of only a few follicles or a high proportion of immature eggs can reduce the number of embryos potentially available for transfer. Simply increasing medication doses, however, does not always improve ovarian response.
A second-opinion review may examine baseline AMH and AFC, medications used, dose changes, trigger timing, follicle measurements and the maturity distribution of collected eggs. In some cases the stimulation or trigger approach can be changed; in others, a low response reflects ovarian reserve and expectations need to be adjusted accordingly.
Sperm factors are not limited to sperm count
Semen analysis provides information about sperm concentration, motility and morphology. More detailed assessment may be appropriate when there is severe male-factor infertility, azoospermia, repeated fertilisation failure or an embryo-development problem. Collection conditions, recent febrile illness, medications and sperm-preparation methods can also be relevant.
ICSI can reduce some fertilisation problems, but it does not eliminate every sperm-related factor affecting embryo development. Tests such as sperm DNA fragmentation should not be used routinely for every patient and should be considered in the context of the clinical history.
Why might fertilisation fail to occur?
Failure of fertilisation despite exposure of mature eggs to sperm may relate to oocyte activation, sperm function, egg maturity or laboratory factors. If conventional IVF was used previously, ICSI may be discussed for a subsequent cycle. Complete fertilisation failure despite ICSI is uncommon and requires specific assessment.
A low fertilisation rate in one cycle does not mean the same pattern will necessarily recur. It is useful to review how many mature eggs fertilised normally, whether abnormal fertilisation occurred and the timing documented in the embryology report.
Discover Ventus IVF and our treatment approach
Treatment decisions are shaped not by a single laboratory result, but by your medical history, expectations and the full context of your treatment journey.
Why do some embryos stop developing?
Not every fertilised egg develops into a healthy blastocyst. Embryo development depends on genetic material from the egg and sperm as well as cellular energy and other biological processes. The proportion of chromosomally abnormal embryos increases with age, although abnormal embryos can also occur at younger ages.
The laboratory environment, incubators, culture systems and embryologist experience are important, but the laboratory cannot change every biological characteristic of an embryo. An embryo that looks morphologically good may still be chromosomally abnormal; morphology is not a genetic test.
Uterine and endometrial factors
Polyps, fibroids that distort the uterine cavity, adhesions or congenital uterine differences can affect implantation. Ultrasound, saline-infusion sonography or hysteroscopy may be used when clinically indicated. Routine hysteroscopy is not required after every unsuccessful transfer.
Endometrial thickness and appearance, together with hormone levels around the time of transfer, may be reviewed. Conditions such as chronic endometritis can be investigated in selected patients, but the benefit of multiple biopsies and immune tests for every patient has not been established.
Can the embryo transfer technique affect the outcome?
Embryo transfer is generally a brief and straightforward procedure. The report may document catheter passage into the uterus, ultrasound guidance, the site of embryo deposition and any procedural difficulty. A difficult transfer, cervical anatomy or uterine contractions may affect the process in some cases.
Prolonged bed rest after embryo transfer has not been shown to improve success. The embryo does not fall out when a person stands up, so an unsuccessful outcome should not be attributed to normal daily movement.
Embryo genetics
Chromosomal abnormalities in the embryo are an important cause of implantation failure, and their likelihood rises particularly with maternal age. PGT-A may be discussed in selected patient groups to assess embryo chromosome number, but it is not mandatory for every couple and does not guarantee live birth.
For people with only a small number of embryos, the benefits and limitations of testing should be considered carefully. Genetic counselling may be required for mosaic results or embryos for which no conclusive result is obtained.
What is recurrent implantation failure?
Fixed definitions such as “three failed transfers means I definitely have an implantation problem” are not appropriate for every patient. The number of embryos transferred, developmental stage, embryo characteristics, maternal age and PGT status should be considered. ESHRE emphasises an individualised approach to recurrent implantation failure and cautions against routine use of numerous tests and treatments with insufficient evidence.
Immune therapies, intralipid, PRP, endometrial scratching, ERA-type tests or anticoagulation treatments are often promoted online. The evidence supporting these approaches is not equivalent. Add-on procedures should not be used simply to “do something more”; potential benefit, risk and cost should be explained.
Which documents are useful for a second opinion?
- Stimulation protocol and total medication doses
- Ultrasound and hormone-monitoring records
- Egg-retrieval report and number of mature eggs
- Semen analysis and sperm-preparation report
- Fertilisation, day-3 and blastocyst-development reports
- Embryo images or time-lapse records, if available
- Transfer report, endometrial measurement and medications used
- Beta-hCG results and, if pregnancy occurred, ultrasound and pregnancy-loss reports
- Genetic laboratory report if PGT was performed
These documents are reviewed not to prove that a previous clinic performed poorly, but to understand where useful information may have been lost and which stage of treatment deserves closer review.
In some IVF cycles, pregnancy does not occur even when the process appears appropriate throughout. Before turning to add-on treatments with weak evidence, the fundamental data and realistic probabilities should be reviewed.
Frequently Asked Questions
Why does IVF fail?
Many factors can play a role, including egg and sperm characteristics, embryo chromosome status, the uterine environment and the transfer process. Sometimes no single cause is identified.
Why might a good-quality embryo not implant?
An embryo’s appearance under the microscope does not guarantee that it is genetically normal. Uterine factors and biological probability also affect the outcome.
Can movement after embryo transfer cause failure?
There is no evidence that normal daily movement causes an embryo to fall out or that bed rest improves success.
After how many unsuccessful transfers should further evaluation be considered?
Rather than using a fixed number, age, the number and characteristics of transferred embryos, PGT status and treatment history should be considered together.
Is PGT needed after every unsuccessful IVF cycle?
No. Whether PGT is appropriate depends on age, embryo number, genetic history and previous outcomes.
Which documents are reviewed for a second opinion?
The stimulation protocol, egg retrieval, fertilisation, embryo development, transfer and any available genetic reports are reviewed.
Sources and medical review note
This article is for general information and has been prepared with reference to current guidance from the institutional sources listed below. It does not replace an individual diagnosis or treatment plan.